Clinical Trials on Hyperhidrosis in Austria

Total 8 results

Botanix Pharmaceuticals

Completed

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) (CardiganI)

Axillary Hyperhidrosis

United States
Botanix Pharmaceuticals

Completed

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) (CARDIGANII)

Axillary Hyperhidrosis

United States
GlaxoSmithKline

Completed

Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis

Hyperhidrosis

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects

Hyperhidrosis

United States, Canada
Journey Medical Corporation

Completed

Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States, Canada
Allergan

Completed

Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis

Hyperhidrosis

United States
Journey Medical Corporation

Completed

Study of Glycopyrronium in Axillary Hyperhydrosis

Hyperhidrosis

United States, Germany
Journey Medical Corporation

Completed

Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis

Hyperhidrosis

United States, Germany

3

Subscribe